Influence of a low-carbohydrate diet on endothelial microvesicles in overweight women

Appl Physiol Nutr Metab. 2016 May;41(5):522-7. doi: 10.1139/apnm-2015-0507. Epub 2016 Mar 10.

Abstract

Low-carbohydrate diets (LCD) are increasing in popularity, but their effect on vascular health has been questioned. Endothelial microvesicles (EMV) are membrane-derived vesicles with the potential to act as a sensitive prognostic biomarker of vascular health and endothelial function. The aim of this study was to examine the influence of a LCD on EMV and other endothelial biomarkers of protein origin. Twenty-four overweight women (age, 48.4 ± 0.6 years; height, 1.60 ± 0.07 m; body mass, 76.5 ± 9.1 kg; body mass index, 28.1 ± 2.7 kg·m(-2); waist circumference, 84.1 ± 7.4 cm; mean ± standard deviation) were randomised to either 24 weeks on their normal diet (ND) or a LCD, after which they crossed over to 24 weeks on the alternative diet. Participants were assisted in reducing carbohydrate intake, but not below 40 g·day(-1). Body composition and endothelial biomarkers were assessed at the crossover point and at the end of the study. Daily carbohydrate intake (87 ± 7 versus 179 ± 11 g) and the percentage of energy derived from carbohydrate (29% versus 44%) were lower (p < 0.05) on the LCD compared to the ND, but absolute fat and saturated fat intake were unchanged. Body mass and waist circumference were 3.7 ± 0.8 kg and 3.5 ± 1.0 cm lower (p < 0.05), respectively, after the LCD compared with the ND phases. CD31(+)CD41(-)EMV, soluble (s) thrombomodulin, sE-selectin, sP-selectin, serum amyloid A and C-reactive protein were lower (p < 0.05) after the LCD compared to the ND, but serum lipids and apolipoproteins were not different. EMV along with a range of endothelial and inflammatory biomarkers are reduced by a LCD that involves modest weight loss.

Keywords: biomarqueurs endothéliaux; endothelial biomarkers; microparticles; microparticules; perte de poids; santé vasculaire; vascular health; weight loss.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Apolipoproteins / blood
  • Biomarkers / blood
  • Body Composition
  • Body Mass Index
  • Body Weight
  • C-Reactive Protein / metabolism
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Cross-Over Studies
  • Diet, Carbohydrate-Restricted*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / analysis
  • Dietary Fats / administration & dosage
  • Dietary Fats / analysis
  • E-Selectin / blood
  • Endothelium, Vascular / metabolism*
  • Energy Intake
  • Exercise
  • Fatty Acids / administration & dosage
  • Fatty Acids / analysis
  • Female
  • Humans
  • Microvessels / metabolism*
  • Middle Aged
  • Overweight*
  • P-Selectin / blood
  • Serum Amyloid A Protein / metabolism
  • Thrombomodulin / blood
  • Triglycerides / blood
  • Waist Circumference
  • Weight Loss

Substances

  • Apolipoproteins
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Dietary Carbohydrates
  • Dietary Fats
  • E-Selectin
  • Fatty Acids
  • P-Selectin
  • Serum Amyloid A Protein
  • Thrombomodulin
  • Triglycerides
  • C-Reactive Protein